Literature DB >> 30327932

Silybin and metabolic disorders.

Pasquale Pignatelli1, Roberto Carnevale2, Danilo Menichelli3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30327932     DOI： 10.1007/s11739-018-1968-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  12 in total

1.  A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations.

Authors:  A Federico; M Trappoliere; C Tuccillo; I de Sio; A Di Leva; C Del Vecchio Blanco; C Loguercio
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 2.  Nutrition, supplements, and vitamins in platelet function and bleeding.

Authors:  Francesco Violi; Pasquale Pignatelli; Stefania Basili
Journal:  Circulation       Date:  2010-03-02       Impact factor: 29.690

Review 3.  Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.

Authors:  Francesca Santilli; Domenico Lapenna; Sara La Barba; Giovanni Davì
Journal:  Free Radic Biol Med       Date:  2014-12-18       Impact factor: 7.376

4.  Metabolic and vascular effects of silybin in hypertensive patients with high 1-h post-load plasma glucose.

Authors:  Angela Sciacqua; Maria Perticone; Giovanni Tripepi; Desire Addesi; Velia Cassano; Raffaele Maio; Giorgio Sesti; Francesco Perticone
Journal:  Intern Emerg Med       Date:  2018-09-19       Impact factor: 3.397

5.  Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.

Authors:  F Lirussi; A Beccarello; G Zanette; A De Monte; V Donadon; M Velussi; G Crepaldi
Journal:  Diabetes Nutr Metab       Date:  2002-08

Review 6.  Platelet oxidative stress and thrombosis.

Authors:  Francesco Violi; Pasquale Pignatelli
Journal:  Thromb Res       Date:  2011-12-29       Impact factor: 3.944

7.  The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial.

Authors:  H Fallah Huseini; B Larijani; R Heshmat; H Fakhrzadeh; B Radjabipour; T Toliat; Mohsin Raza
Journal:  Phytother Res       Date:  2006-12       Impact factor: 5.878

8.  Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress.

Authors:  Francesco Violi; Pasquale Pignatelli; Claudio Pignata; Alessandro Plebani; Paolo Rossi; Valerio Sanguigni; Roberto Carnevale; Annarosa Soresina; Andrea Finocchi; Emilia Cirillo; Elisa Catasca; Francesco Angelico; Lorenzo Loffredo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 9.  Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Licia Polimeni; Maria Del Ben; Francesco Baratta; Ludovica Perri; Fabiana Albanese; Daniele Pastori; Francesco Violi; Francesco Angelico
Journal:  World J Hepatol       Date:  2015-06-08

10.  Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study.

Authors:  Patrick Trouillas; Philippe Marsal; Alena Svobodová; Jitka Vostálová; Radek Gazák; Jan Hrbác; Petr Sedmera; Vladimír Kren; Roberto Lazzaroni; Jean-Luc Duroux; Daniela Walterová
Journal:  J Phys Chem A       Date:  2008-01-15       Impact factor: 2.781
View more
  3 in total

1.  Silybin induces endothelium-dependent vasodilation via TRPV4 channels in mouse mesenteric arteries.

Authors:  Xin Wen; Yidi Peng; Bohao Zheng; Shaying Yang; Jing Han; Fan Yu; Tingting Zhou; Li Geng; Zhiming Yu; Lei Feng
Journal:  Hypertens Res       Date:  2022-09-02       Impact factor: 5.528

2.  Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity.

Authors:  Zibo Wei; Shuangyan Ye; Haipeng Feng; Chong Zeng; Xinhuai Dong; Xiaokang Zeng; Liming Zeng; Xu Lin; Qiuzhen Liu; Jie Yao
Journal:  Cancer Sci       Date:  2022-07-21       Impact factor: 6.518

Review 3.  Therapeutic Properties of Flavonoids in Treatment of Cancer through Autophagic Modulation: A Systematic Review.

Authors:  Guilherme Vinício de Sousa Silva; Ana Luiza Vieira Ferreira Guimarães Lopes; Isis Carolina Viali; Lucas Zannini Medeiros Lima; Matheus Ribeiro Bizuti; Fabiana Brum Haag; Débora Tavares de Resende Silva
Journal:  Chin J Integr Med       Date:  2022-07-09       Impact factor: 2.626
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.